4basebio PLC4basebio PLC4basebio PLC

4basebio PLC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪204.99 M‬EUR
−0.9258EUR
‪−8.84 M‬EUR
‪583.60 K‬EUR
‪5.22 M‬
Beta (1Y)
0.04
Employees (FY)
84
Change (1Y)
+23 +37.70%
Revenue / Employee (1Y)
‪6.95 K‬EUR
Net income / Employee (1Y)
‪−105.24 K‬EUR

About 4BASEBIO PLC ORD EUR1


CEO
Heikki Lanckriet
Headquarters
Cambridge
Founded
2020
ISIN
GB00BMCLYF79
FIGI
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy


Frequently Asked Questions


The current price of A3CWA4 is 13.1000 EUR — it hasn't changed in the past 24 hours. Watch 4basebio PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange 4basebio PLC stocks are traded under the ticker A3CWA4.
A3CWA4 reached its all-time high on Jan 21, 2025 with the price of 14.2000 EUR, and its all-time low was 12.6000 EUR and was reached on Feb 12, 2025. View more price dynamics on A3CWA4 chart.
See other stocks reaching their highest and lowest prices.
A3CWA4 stock is 2.29% volatile and has beta coefficient of 0.04. Track 4basebio PLC stock price on the chart and check out the list of the most volatile stocks — is 4basebio PLC there?
Today 4basebio PLC has the market capitalization of ‪204.65 M‬, it has decreased by −0.62% over the last week.
Yes, you can track 4basebio PLC financials in yearly and quarterly reports right on TradingView.
4basebio PLC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
A3CWA4 net income for the last half-year is ‪−6.76 M‬ EUR, while the previous report showed ‪−4.74 M‬ EUR of net income which accounts for −42.63% change. Track more 4basebio PLC financial stats to get the full picture.
No, A3CWA4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 12, 2025, the company has 84.00 employees. See our rating of the largest employees — is 4basebio PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4basebio PLC EBITDA is ‪−8.89 M‬ EUR, and current EBITDA margin is ‪−1.25 K‬%. See more stats in 4basebio PLC financial statements.
Like other stocks, A3CWA4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4basebio PLC stock right from TradingView charts — choose your broker and connect to your account.